PMID- 22769726 OWN - NLM STAT- MEDLINE DCOM- 20121126 LR - 20240321 IS - 1520-4995 (Electronic) IS - 0006-2960 (Print) IS - 0006-2960 (Linking) VI - 51 IP - 30 DP - 2012 Jul 31 TI - Specific fluorine labeling of the HyHEL10 antibody affects antigen binding and dynamics. PG - 6017-27 AB - To more fully understand the molecular mechanisms responsible for variations in binding affinity with antibody maturation, we explored the use of site specific fluorine labeling and (19)F nuclear magnetic resonance (NMR). Several single-chain (scFv) antibodies, derived from an affinity-matured series of anti-hen egg white lysozyme (HEL) mouse IgG1, were constructed with either complete or individual replacement of tryptophan residues with 5-fluorotryptophan ((5F)W). An array of biophysical techniques was used to gain insight into the impact of fluorine substitution on the overall protein structure and antigen binding. SPR measurements indicated that (5F)W incorporation lowered binding affinity for the HEL antigen. The degree of analogue impact was residue-dependent, and the greatest decrease in affinity was observed when (5F)W was substituted for residues near the binding interface. In contrast, corresponding crystal structures in complex with HEL were essentially indistinguishable from the unsubstituted antibody. (19)F NMR analysis showed severe overlap of signals in the free fluorinated protein that was resolved upon binding to antigen, suggesting very distinct chemical environments for each (5F)W in the complex. Preliminary relaxation analysis suggested the presence of chemical exchange in the antibody-antigen complex that could not be observed by X-ray crystallography. These data demonstrate that fluorine NMR can be an extremely useful tool for discerning structural changes in scFv antibody-antigen complexes with altered function that may not be discernible by other biophysical techniques. FAU - Acchione, Mauro AU - Acchione M AD - Structural Biophysics Laboratory, Center for Cancer Research, Frederick National Laboratory for Cancer Research, Frederick, MD 21702, USA. FAU - Lee, Yi-Chien AU - Lee YC FAU - DeSantis, Morgan E AU - DeSantis ME FAU - Lipschultz, Claudia A AU - Lipschultz CA FAU - Wlodawer, Alexander AU - Wlodawer A FAU - Li, Mi AU - Li M FAU - Shanmuganathan, Aranganathan AU - Shanmuganathan A FAU - Walter, Richard L AU - Walter RL FAU - Smith-Gill, Sandra AU - Smith-Gill S FAU - Barchi, Joseph J Jr AU - Barchi JJ Jr LA - eng GR - HHSN261200800001C/RC/CCR NIH HHS/United States GR - HHSN261200800001E/CA/NCI NIH HHS/United States GR - Z01 BC010739-03/Intramural NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural PT - Research Support, N.I.H., Intramural PT - Research Support, Non-U.S. Gov't PT - Research Support, U.S. Gov't, Non-P.H.S. DEP - 20120716 PL - United States TA - Biochemistry JT - Biochemistry JID - 0370623 RN - 0 (Antibodies, Monoclonal) RN - 0 (Antigens) RN - 0 (Immunoglobulin G) RN - 284SYP0193 (Fluorine) RN - EC 3.2.1.- (hen egg lysozyme) RN - EC 3.2.1.17 (Muramidase) SB - IM MH - Animals MH - Antibodies, Monoclonal/*chemistry/metabolism MH - Antigens/chemistry/*metabolism MH - Binding Sites, Antibody MH - Crystallography, X-Ray/methods MH - Fluorine/*metabolism MH - Immunoglobulin G/chemistry/metabolism MH - Isotope Labeling/methods MH - Mice MH - Molecular Dynamics Simulation MH - Muramidase/*chemistry/immunology/metabolism MH - Nuclear Magnetic Resonance, Biomolecular/methods MH - Protein Binding/immunology MH - Protein Structure, Secondary MH - Protein Structure, Tertiary PMC - PMC3508667 MID - NIHMS421456 COIS- The authors declare no competing financial interest. EDAT- 2012/07/10 06:00 MHDA- 2012/12/10 06:00 PMCR- 2012/11/28 CRDT- 2012/07/10 06:00 PHST- 2012/07/10 06:00 [entrez] PHST- 2012/07/10 06:00 [pubmed] PHST- 2012/12/10 06:00 [medline] PHST- 2012/11/28 00:00 [pmc-release] AID - 10.1021/bi300455t [doi] PST - ppublish SO - Biochemistry. 2012 Jul 31;51(30):6017-27. doi: 10.1021/bi300455t. Epub 2012 Jul 16.